Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

Cited In for PubMed (Select 2592361)

1.

A Novel Mutation in the CYP11B1 Gene Causes Steroid 11β-Hydroxylase Deficient Congenital Adrenal Hyperplasia with Reversible Cardiomyopathy.

Alqahtani MA, Shati AA, Zou M, Alsuheel AM, Alhayani AA, Al-Qahtani SM, Gilban HM, Meyer BF, Shi Y.

Int J Endocrinol. 2015;2015:595164. doi: 10.1155/2015/595164. Epub 2015 Jul 22.

2.

A recombinant CYP11B1 dependent Escherichia coli biocatalyst for selective cortisol production and optimization towards a preparative scale.

Schiffer L, Anderko S, Hobler A, Hannemann F, Kagawa N, Bernhardt R.

Microb Cell Fact. 2015 Feb 25;14:25. doi: 10.1186/s12934-015-0209-5.

3.

Interfering with mineralocorticoid receptor activation: the past, present, and future.

Dorrance AM.

F1000Prime Rep. 2014 Aug 1;6:61. doi: 10.12703/P6-61. eCollection 2014. Review.

4.

Optimization of the First Selective Steroid-11β-hydroxylase (CYP11B1) Inhibitors for the Treatment of Cortisol Dependent Diseases.

Hille UE, Zimmer C, Haupenthal J, Hartmann RW.

ACS Med Chem Lett. 2011 Jun 3;2(8):559-64. doi: 10.1021/ml100283h. eCollection 2011 Aug 11.

5.

First Selective CYP11B1 Inhibitors for the Treatment of Cortisol-Dependent Diseases.

Hille UE, Zimmer C, Vock CA, Hartmann RW.

ACS Med Chem Lett. 2010 Oct 22;2(1):2-6. doi: 10.1021/ml100071j. eCollection 2011 Jan 13.

6.

Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations.

Menabò S, Polat S, Baldazzi L, Kulle AE, Holterhus PM, Grötzinger J, Fanelli F, Balsamo A, Riepe FG.

Eur J Hum Genet. 2014 May;22(5):610-6. doi: 10.1038/ejhg.2013.197. Epub 2013 Sep 11.

7.

Human cytochromes P450 in health and disease.

Nebert DW, Wikvall K, Miller WL.

Philos Trans R Soc Lond B Biol Sci. 2013 Jan 6;368(1612):20120431. doi: 10.1098/rstb.2012.0431. Print 2013 Feb 19. Review.

8.

Comparison of aldosterone production among human adrenocortical cell lines.

Wang T, Rowland JG, Parmar J, Nesterova M, Seki T, Rainey WE.

Horm Metab Res. 2012 Mar;44(3):245-50. doi: 10.1055/s-0031-1298019. Epub 2012 Jan 20.

9.

Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL).

Xing Y, Rainey WE, Apolzan JW, Francone OL, Harris RB, Bollag WB.

Endocrinology. 2012 Feb;153(2):721-31. doi: 10.1210/en.2011-1752. Epub 2011 Dec 20.

10.

Alteration in accumulated aldosterone synthesis as a result of N-terminal cleavage of aldosterone synthase.

Adams BP, Bose HS.

Mol Pharmacol. 2012 Mar;81(3):465-74. doi: 10.1124/mol.111.076471. Epub 2011 Dec 19.

11.

Mineralocorticoid hypertension.

Gupta V.

Indian J Endocrinol Metab. 2011 Oct;15 Suppl 4:S298-312. doi: 10.4103/2230-8210.86972.

12.

Genome-based analysis of the nonhuman primate Macaca fascicularis as a model for drug safety assessment.

Ebeling M, Küng E, See A, Broger C, Steiner G, Berrera M, Heckel T, Iniguez L, Albert T, Schmucki R, Biller H, Singer T, Certa U.

Genome Res. 2011 Oct;21(10):1746-56. doi: 10.1101/gr.123117.111. Epub 2011 Aug 23.

13.

Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor.

Essick EE, Sam F.

Int J Hypertens. 2011;2011:346985. doi: 10.4061/2011/346985. Epub 2011 May 22.

14.

Clinical and molecular pharmacology of etomidate.

Forman SA.

Anesthesiology. 2011 Mar;114(3):695-707. doi: 10.1097/ALN.0b013e3181ff72b5. Review.

15.

Aldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone synthase (CYP11B2).

Xing Y, Cohen A, Rothblat G, Sankaranarayanan S, Weibel G, Royer L, Francone OL, Rainey WE.

Endocrinology. 2011 Mar;152(3):751-63. doi: 10.1210/en.2010-1049. Epub 2011 Jan 14.

16.

Partial defect in the cholesterol side-chain cleavage enzyme P450scc (CYP11A1) resembling nonclassic congenital lipoid adrenal hyperplasia.

Sahakitrungruang T, Tee MK, Blackett PR, Miller WL.

J Clin Endocrinol Metab. 2011 Mar;96(3):792-8. doi: 10.1210/jc.2010-1828. Epub 2010 Dec 15.

17.

The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Miller WL, Auchus RJ.

Endocr Rev. 2011 Feb;32(1):81-151. doi: 10.1210/er.2010-0013. Epub 2010 Nov 4. Review. Erratum in: Endocr Rev. 2011 Aug;32(4):579.

18.

Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency.

Parajes S, Loidi L, Reisch N, Dhir V, Rose IT, Hampel R, Quinkler M, Conway GS, Castro-Feijóo L, Araujo-Vilar D, Pombo M, Dominguez F, Williams EL, Cole TR, Kirk JM, Kaminsky E, Rumsby G, Arlt W, Krone N.

J Clin Endocrinol Metab. 2010 Feb;95(2):779-88. doi: 10.1210/jc.2009-0651. Epub 2010 Jan 20.

19.

Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factor.

Somekawa S, Imagawa K, Naya N, Takemoto Y, Onoue K, Okayama S, Takeda Y, Kawata H, Horii M, Nakajima T, Uemura S, Mochizuki N, Saito Y.

Endocrinology. 2009 Jul;150(7):3110-7. doi: 10.1210/en.2008-1624. Epub 2009 Apr 2.

20.

Adaptive evolution of mammalian aromatases: lessons from Suiformes.

Conley AJ, Corbin CJ, Hughes AL.

J Exp Zool A Ecol Genet Physiol. 2009 Jun 1;311(5):346-57. doi: 10.1002/jez.451. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk